|
COPS8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.762580E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.815200E-01 |
| Normal-vs-Stage2 |
9.110200E-01 |
| Normal-vs-Stage3 |
1.350250E-02 |
| Normal-vs-Stage4 |
5.409800E-01 |
| Stage1-vs-Stage2 |
5.786400E-01 |
| Stage1-vs-Stage3 |
2.981500E-02 |
| Stage1-vs-Stage4 |
8.581600E-01 |
| Stage2-vs-Stage3 |
5.903700E-02 |
| Stage2-vs-Stage4 |
5.732000E-01 |
| Stage3-vs-Stage4 |
1.665400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.774600E-01 |
| Normal-vs-AfricanAmerican |
5.723500E-02 |
| Normal-vs-Asian |
3.060500E-02 |
| Caucasian-vs-AfricanAmerican |
2.119600E-01 |
| Caucasian-vs-Asian |
2.269800E-01 |
| AfricanAmerican-vs-Asian |
2.994000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.592200E-02 |
| Normal-vs-Female |
9.858000E-01 |
| Male-vs-Female |
3.705700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.706000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.016000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.279000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.840400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.277000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.025200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.099600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.199000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.090600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.926400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.659400E-01 |
| Normal-vs-Grade 2 |
9.056400E-01 |
| Normal-vs-Grade 3 |
2.717500E-02 |
| Normal-vs-Grade 4 |
3.272000E-02 |
| Grade 1-vs-Grade 2 |
4.519800E-01 |
| Grade 1-vs-Grade 3 |
8.670100E-02 |
| Grade 1-vs-Grade 4 |
7.957800E-02 |
| Grade 2-vs-Grade 3 |
1.159620E-02 |
| Grade 2-vs-Grade 4 |
1.677580E-02 |
| Grade 3-vs-Grade 4 |
5.059600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.070200E-01 |
| Normal-vs-ccB subtype |
7.701300E-03 |
| ccA subtype-vs-ccB subtype |
4.00440000000168E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.515800E-01 |
| Normal-vs-N1 |
7.333400E-01 |
| N0-vs-N1 |
9.183600E-01 |
|
|
